No lipiodol, no beads—another transcatheter arterial chemoembolization (TACE) with fine cisplatin powder and porous gelatin particles for TACE‐naïve, multifocal, up‐to‐seven out hepatocellular carcinoma

Documenti analoghi

• Safety of transcatheter arterial chemoembolization for hepatocellular carcinoma in older adults aged ≥ 85 years: A single‐institution retrospective preliminary study
  di: Atsushi Saiga, et al.
  Pubblicazione: (2025)
• Efficacy and safety of lenvatinib‐transcatheter arterial chemoembolization sequential therapy for hepatocellular carcinoma within the up‐to‐seven criteria
  di: Shigeo Shimose, et al.
  Pubblicazione: (2025)
• A study comparing the cost‐effectiveness of conventional and drug‐eluting transarterial chemoembolisation (cTACE and DEB‐TACE) for the treatment of hepatocellular carcinoma in an Australian public hospital
  di: Warren Clements, et al.
  Pubblicazione: (2024)
• TACE: Tumor-Aware Counterfactual Explanations
  di: Rossi, Eleonora Beatrice, et al.
  Pubblicazione: (2024)
• Impact of Microparticle Transarterial Chemoembolization (mTACE) on myeloid‐derived suppressor cell subtypes in hepatocellular carcinoma: Clinical correlations and therapeutic implications
  di: Yuanxun Yue, et al.
  Pubblicazione: (2024)